Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Journal of Veterinary Medicine. A, Physiology, Pathology, Clinical Medicine
|
August 20, 2005
Persistent truncus arteriosus in a 6-year-old cat
A P Nicolle, D Tessier-Vetzel, E Begon, et al.
European Journal of Wildlife Research
|
March 28, 2020
Enhancement of wildlife disease surveillance using multiplex quantitative PCR: development of qPCR assays for major pathogens in UK squirrel populations
Timothy D Dale, Phillip C Watts, David Jones, et al.
The British Journal of Dermatology
|
January 17, 2007
A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity
N Poulalhon, E Begon, C Lebbé, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 26, 2021
Frequency of relapse and persistent cutaneous symptoms after a first episode of chilblain-like lesion during the COVID-19 pandemic
P Moghadam, L Frumholtz, L Jaume, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
June 26, 2026
Cumulative live birth rates following testicular sperm extraction in non-obstructive male infertility
Lena Ottou, S Mebroukine, L Ferretti, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 28, 2020
Vascular skin symptoms in COVID-19: a French observational study
J D Bouaziz, T A Duong, M Jachiet, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 22, 2020
Effectiveness and short-term (16-week) tolerance of guselkumab for psoriasis under real-life conditions: a retrospective multicenter study
A-C Fougerousse, P-D Ghislain, Z Reguiai, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 22, 2020
Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19
A-C Fougerousse, M Perrussel, P-A Bécherel, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 3, 2013
Evaluation of risk factors for body weight increment in psoriatic patients on infliximab: a multicentre, cross-sectional study
E Mahé, Z Reguiai, H Barthelemy, et al.
The British Journal of Dermatology
|
February 27, 2018
Safety and efficacy of biological therapies in patients with psoriasis with alcoholic cirrhosis: a French retrospective study of 23 cases
E Begon, N Beneton, C Poiraud, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Journal of Veterinary Medicine. A, Physiology, Pathology, Clinical Medicine
|
August 20, 2005
Persistent truncus arteriosus in a 6-year-old cat
A P Nicolle, D Tessier-Vetzel, E Begon, et al.
European Journal of Wildlife Research
|
March 28, 2020
Enhancement of wildlife disease surveillance using multiplex quantitative PCR: development of qPCR assays for major pathogens in UK squirrel populations
Timothy D Dale, Phillip C Watts, David Jones, et al.
The British Journal of Dermatology
|
January 17, 2007
A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity
N Poulalhon, E Begon, C Lebbé, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 26, 2021
Frequency of relapse and persistent cutaneous symptoms after a first episode of chilblain-like lesion during the COVID-19 pandemic
P Moghadam, L Frumholtz, L Jaume, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
June 26, 2026
Cumulative live birth rates following testicular sperm extraction in non-obstructive male infertility
Lena Ottou, S Mebroukine, L Ferretti, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 28, 2020
Vascular skin symptoms in COVID-19: a French observational study
J D Bouaziz, T A Duong, M Jachiet, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 22, 2020
Effectiveness and short-term (16-week) tolerance of guselkumab for psoriasis under real-life conditions: a retrospective multicenter study
A-C Fougerousse, P-D Ghislain, Z Reguiai, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 22, 2020
Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19
A-C Fougerousse, M Perrussel, P-A Bécherel, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 3, 2013
Evaluation of risk factors for body weight increment in psoriatic patients on infliximab: a multicentre, cross-sectional study
E Mahé, Z Reguiai, H Barthelemy, et al.
The British Journal of Dermatology
|
February 27, 2018
Safety and efficacy of biological therapies in patients with psoriasis with alcoholic cirrhosis: a French retrospective study of 23 cases
E Begon, N Beneton, C Poiraud, et al.
Page
of 4